ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Induced Pluripotent Stem Cells Production Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-33H10204
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Induced Pluripotent Stem Cells Production Market Insights Forecast to 2028
BUY CHAPTERS

Global Induced Pluripotent Stem Cells Production Market Research Report 2025

Code: QYRE-Auto-33H10204
Report
March 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lonza
Axol Bioscience Ltd
Evotec AG
Hitachi
Merck KGaA
Reprocell
Fate Therapeutics
Thermo Fisher Scientific Inc
Applied StemCell, Inc.
StemCellFactory III

Induced Pluripotent Stem Cells Production Market

The global market for Induced Pluripotent Stem Cells Production was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Induced Pluripotent Stem Cells (iPSC) are generated from skin or blood cells that have been reprogrammed into an embryonic-like pluripotent state, allowing to produce an infinite source of any kind of human cell required for therapeutic reasons.
North American market for Induced Pluripotent Stem Cells Production is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Induced Pluripotent Stem Cells Production is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Induced Pluripotent Stem Cells Production include Lonza, Axol Bioscience Ltd., Evotec, Hitachi Ltd., Merck KGaA, REPROCELL Inc., Fate Therapeutics, Thermo Fisher Scientific, Inc., StemCellFactory III, Applied StemCell Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Induced Pluripotent Stem Cells Production, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Induced Pluripotent Stem Cells Production.
The Induced Pluripotent Stem Cells Production market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Induced Pluripotent Stem Cells Production market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Induced Pluripotent Stem Cells Production manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Induced Pluripotent Stem Cells Production Market Report

Report Metric Details
Report Name Induced Pluripotent Stem Cells Production Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Lonza, Axol Bioscience Ltd., Evotec, Hitachi Ltd., Merck KGaA, REPROCELL Inc., Fate Therapeutics, Thermo Fisher Scientific, Inc., StemCellFactory III, Applied StemCell Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Induced Pluripotent Stem Cells Production manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Induced Pluripotent Stem Cells Production in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Induced Pluripotent Stem Cells Production Market report?

Ans: The main players in the Induced Pluripotent Stem Cells Production Market are Lonza, Axol Bioscience Ltd., Evotec, Hitachi Ltd., Merck KGaA, REPROCELL Inc., Fate Therapeutics, Thermo Fisher Scientific, Inc., StemCellFactory III, Applied StemCell Inc.

What are the Application segmentation covered in the Induced Pluripotent Stem Cells Production Market report?

Ans: The Applications covered in the Induced Pluripotent Stem Cells Production Market report are Academic Research, Drug Development, Toxicity Screening, Regenerative Medicine

What are the Type segmentation covered in the Induced Pluripotent Stem Cells Production Market report?

Ans: The Types covered in the Induced Pluripotent Stem Cells Production Market report are Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Others

Recommended Reports

Stem Cell Therapies

Cell Engineering Tools

Regenerative Medicines

1 Induced Pluripotent Stem Cells Production Market Overview
1.1 Product Definition
1.2 Induced Pluripotent Stem Cells Production by Type
1.2.1 Global Induced Pluripotent Stem Cells Production Market Value Comparison by Type (2024 VS 2031)
1.2.2 Hepatocytes
1.2.3 Fibroblasts
1.2.4 Keratinocytes
1.2.5 Amniotic Cells
1.2.6 Others
1.3 Induced Pluripotent Stem Cells Production by Application
1.3.1 Global Induced Pluripotent Stem Cells Production Market Value by Application (2024 VS 2031)
1.3.2 Academic Research
1.3.3 Drug Development
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.4 Global Induced Pluripotent Stem Cells Production Market Size Estimates and Forecasts
1.4.1 Global Induced Pluripotent Stem Cells Production Revenue 2020-2031
1.4.2 Global Induced Pluripotent Stem Cells Production Sales 2020-2031
1.4.3 Global Induced Pluripotent Stem Cells Production Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Induced Pluripotent Stem Cells Production Market Competition by Manufacturers
2.1 Global Induced Pluripotent Stem Cells Production Sales Market Share by Manufacturers (2020-2025)
2.2 Global Induced Pluripotent Stem Cells Production Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Induced Pluripotent Stem Cells Production Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Induced Pluripotent Stem Cells Production, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Induced Pluripotent Stem Cells Production, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Induced Pluripotent Stem Cells Production, Product Type & Application
2.7 Global Key Manufacturers of Induced Pluripotent Stem Cells Production, Date of Enter into This Industry
2.8 Global Induced Pluripotent Stem Cells Production Market Competitive Situation and Trends
2.8.1 Global Induced Pluripotent Stem Cells Production Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Induced Pluripotent Stem Cells Production Players Market Share by Revenue
2.8.3 Global Induced Pluripotent Stem Cells Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Induced Pluripotent Stem Cells Production Market Scenario by Region
3.1 Global Induced Pluripotent Stem Cells Production Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Induced Pluripotent Stem Cells Production Sales by Region: 2020-2031
3.2.1 Global Induced Pluripotent Stem Cells Production Sales by Region: 2020-2025
3.2.2 Global Induced Pluripotent Stem Cells Production Sales by Region: 2026-2031
3.3 Global Induced Pluripotent Stem Cells Production Revenue by Region: 2020-2031
3.3.1 Global Induced Pluripotent Stem Cells Production Revenue by Region: 2020-2025
3.3.2 Global Induced Pluripotent Stem Cells Production Revenue by Region: 2026-2031
3.4 North America Induced Pluripotent Stem Cells Production Market Facts & Figures by Country
3.4.1 North America Induced Pluripotent Stem Cells Production Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Induced Pluripotent Stem Cells Production Sales by Country (2020-2031)
3.4.3 North America Induced Pluripotent Stem Cells Production Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Induced Pluripotent Stem Cells Production Market Facts & Figures by Country
3.5.1 Europe Induced Pluripotent Stem Cells Production Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Induced Pluripotent Stem Cells Production Sales by Country (2020-2031)
3.5.3 Europe Induced Pluripotent Stem Cells Production Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Induced Pluripotent Stem Cells Production Market Facts & Figures by Region
3.6.1 Asia Pacific Induced Pluripotent Stem Cells Production Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Induced Pluripotent Stem Cells Production Sales by Region (2020-2031)
3.6.3 Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Induced Pluripotent Stem Cells Production Market Facts & Figures by Country
3.7.1 Latin America Induced Pluripotent Stem Cells Production Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Induced Pluripotent Stem Cells Production Sales by Country (2020-2031)
3.7.3 Latin America Induced Pluripotent Stem Cells Production Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Induced Pluripotent Stem Cells Production Market Facts & Figures by Country
3.8.1 Middle East and Africa Induced Pluripotent Stem Cells Production Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Country (2020-2031)
3.8.3 Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Induced Pluripotent Stem Cells Production Sales by Type (2020-2031)
4.1.1 Global Induced Pluripotent Stem Cells Production Sales by Type (2020-2025)
4.1.2 Global Induced Pluripotent Stem Cells Production Sales by Type (2026-2031)
4.1.3 Global Induced Pluripotent Stem Cells Production Sales Market Share by Type (2020-2031)
4.2 Global Induced Pluripotent Stem Cells Production Revenue by Type (2020-2031)
4.2.1 Global Induced Pluripotent Stem Cells Production Revenue by Type (2020-2025)
4.2.2 Global Induced Pluripotent Stem Cells Production Revenue by Type (2026-2031)
4.2.3 Global Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2020-2031)
4.3 Global Induced Pluripotent Stem Cells Production Price by Type (2020-2031)
5 Segment by Application
5.1 Global Induced Pluripotent Stem Cells Production Sales by Application (2020-2031)
5.1.1 Global Induced Pluripotent Stem Cells Production Sales by Application (2020-2025)
5.1.2 Global Induced Pluripotent Stem Cells Production Sales by Application (2026-2031)
5.1.3 Global Induced Pluripotent Stem Cells Production Sales Market Share by Application (2020-2031)
5.2 Global Induced Pluripotent Stem Cells Production Revenue by Application (2020-2031)
5.2.1 Global Induced Pluripotent Stem Cells Production Revenue by Application (2020-2025)
5.2.2 Global Induced Pluripotent Stem Cells Production Revenue by Application (2026-2031)
5.2.3 Global Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2020-2031)
5.3 Global Induced Pluripotent Stem Cells Production Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Lonza
6.1.1 Lonza Company Information
6.1.2 Lonza Description and Business Overview
6.1.3 Lonza Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Lonza Induced Pluripotent Stem Cells Production Product Portfolio
6.1.5 Lonza Recent Developments/Updates
6.2 Axol Bioscience Ltd.
6.2.1 Axol Bioscience Ltd. Company Information
6.2.2 Axol Bioscience Ltd. Description and Business Overview
6.2.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Product Portfolio
6.2.5 Axol Bioscience Ltd. Recent Developments/Updates
6.3 Evotec
6.3.1 Evotec Company Information
6.3.2 Evotec Description and Business Overview
6.3.3 Evotec Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Evotec Induced Pluripotent Stem Cells Production Product Portfolio
6.3.5 Evotec Recent Developments/Updates
6.4 Hitachi Ltd.
6.4.1 Hitachi Ltd. Company Information
6.4.2 Hitachi Ltd. Description and Business Overview
6.4.3 Hitachi Ltd. Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hitachi Ltd. Induced Pluripotent Stem Cells Production Product Portfolio
6.4.5 Hitachi Ltd. Recent Developments/Updates
6.5 Merck KGaA
6.5.1 Merck KGaA Company Information
6.5.2 Merck KGaA Description and Business Overview
6.5.3 Merck KGaA Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck KGaA Induced Pluripotent Stem Cells Production Product Portfolio
6.5.5 Merck KGaA Recent Developments/Updates
6.6 REPROCELL Inc.
6.6.1 REPROCELL Inc. Company Information
6.6.2 REPROCELL Inc. Description and Business Overview
6.6.3 REPROCELL Inc. Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2020-2025)
6.6.4 REPROCELL Inc. Induced Pluripotent Stem Cells Production Product Portfolio
6.6.5 REPROCELL Inc. Recent Developments/Updates
6.7 Fate Therapeutics
6.7.1 Fate Therapeutics Company Information
6.7.2 Fate Therapeutics Description and Business Overview
6.7.3 Fate Therapeutics Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Fate Therapeutics Induced Pluripotent Stem Cells Production Product Portfolio
6.7.5 Fate Therapeutics Recent Developments/Updates
6.8 Thermo Fisher Scientific, Inc.
6.8.1 Thermo Fisher Scientific, Inc. Company Information
6.8.2 Thermo Fisher Scientific, Inc. Description and Business Overview
6.8.3 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Product Portfolio
6.8.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
6.9 StemCellFactory III
6.9.1 StemCellFactory III Company Information
6.9.2 StemCellFactory III Description and Business Overview
6.9.3 StemCellFactory III Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2020-2025)
6.9.4 StemCellFactory III Induced Pluripotent Stem Cells Production Product Portfolio
6.9.5 StemCellFactory III Recent Developments/Updates
6.10 Applied StemCell Inc.
6.10.1 Applied StemCell Inc. Company Information
6.10.2 Applied StemCell Inc. Description and Business Overview
6.10.3 Applied StemCell Inc. Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Applied StemCell Inc. Induced Pluripotent Stem Cells Production Product Portfolio
6.10.5 Applied StemCell Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Induced Pluripotent Stem Cells Production Industry Chain Analysis
7.2 Induced Pluripotent Stem Cells Production Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Induced Pluripotent Stem Cells Production Production Mode & Process Analysis
7.4 Induced Pluripotent Stem Cells Production Sales and Marketing
7.4.1 Induced Pluripotent Stem Cells Production Sales Channels
7.4.2 Induced Pluripotent Stem Cells Production Distributors
7.5 Induced Pluripotent Stem Cells Production Customer Analysis
8 Induced Pluripotent Stem Cells Production Market Dynamics
8.1 Induced Pluripotent Stem Cells Production Industry Trends
8.2 Induced Pluripotent Stem Cells Production Market Drivers
8.3 Induced Pluripotent Stem Cells Production Market Challenges
8.4 Induced Pluripotent Stem Cells Production Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Lonza
Axol Bioscience Ltd
Evotec AG
Hitachi
Merck KGaA
Reprocell
Fate Therapeutics
Thermo Fisher Scientific Inc
Applied StemCell, Inc.
StemCellFactory III
List of Tables
 Table 1. Global Induced Pluripotent Stem Cells Production Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Induced Pluripotent Stem Cells Production Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Induced Pluripotent Stem Cells Production Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Induced Pluripotent Stem Cells Production Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Induced Pluripotent Stem Cells Production Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Induced Pluripotent Stem Cells Production Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Induced Pluripotent Stem Cells Production Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Induced Pluripotent Stem Cells Production Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Induced Pluripotent Stem Cells Production, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Induced Pluripotent Stem Cells Production, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Induced Pluripotent Stem Cells Production, Product Type & Application
 Table 12. Global Key Manufacturers of Induced Pluripotent Stem Cells Production, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Induced Pluripotent Stem Cells Production by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells Production as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Induced Pluripotent Stem Cells Production Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Induced Pluripotent Stem Cells Production Sales by Region (2020-2025) & (K Units)
 Table 18. Global Induced Pluripotent Stem Cells Production Sales Market Share by Region (2020-2025)
 Table 19. Global Induced Pluripotent Stem Cells Production Sales by Region (2026-2031) & (K Units)
 Table 20. Global Induced Pluripotent Stem Cells Production Sales Market Share by Region (2026-2031)
 Table 21. Global Induced Pluripotent Stem Cells Production Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Region (2020-2025)
 Table 23. Global Induced Pluripotent Stem Cells Production Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Region (2026-2031)
 Table 25. North America Induced Pluripotent Stem Cells Production Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Induced Pluripotent Stem Cells Production Sales by Country (2020-2025) & (K Units)
 Table 27. North America Induced Pluripotent Stem Cells Production Sales by Country (2026-2031) & (K Units)
 Table 28. North America Induced Pluripotent Stem Cells Production Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Induced Pluripotent Stem Cells Production Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Induced Pluripotent Stem Cells Production Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Induced Pluripotent Stem Cells Production Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Induced Pluripotent Stem Cells Production Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Induced Pluripotent Stem Cells Production Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Induced Pluripotent Stem Cells Production Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Induced Pluripotent Stem Cells Production Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Induced Pluripotent Stem Cells Production Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Induced Pluripotent Stem Cells Production Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Induced Pluripotent Stem Cells Production Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Induced Pluripotent Stem Cells Production Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Induced Pluripotent Stem Cells Production Sales (K Units) by Type (2020-2025)
 Table 51. Global Induced Pluripotent Stem Cells Production Sales (K Units) by Type (2026-2031)
 Table 52. Global Induced Pluripotent Stem Cells Production Sales Market Share by Type (2020-2025)
 Table 53. Global Induced Pluripotent Stem Cells Production Sales Market Share by Type (2026-2031)
 Table 54. Global Induced Pluripotent Stem Cells Production Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Induced Pluripotent Stem Cells Production Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2020-2025)
 Table 57. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2026-2031)
 Table 58. Global Induced Pluripotent Stem Cells Production Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Induced Pluripotent Stem Cells Production Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Induced Pluripotent Stem Cells Production Sales (K Units) by Application (2020-2025)
 Table 61. Global Induced Pluripotent Stem Cells Production Sales (K Units) by Application (2026-2031)
 Table 62. Global Induced Pluripotent Stem Cells Production Sales Market Share by Application (2020-2025)
 Table 63. Global Induced Pluripotent Stem Cells Production Sales Market Share by Application (2026-2031)
 Table 64. Global Induced Pluripotent Stem Cells Production Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Induced Pluripotent Stem Cells Production Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2020-2025)
 Table 67. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2026-2031)
 Table 68. Global Induced Pluripotent Stem Cells Production Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Induced Pluripotent Stem Cells Production Price (USD/Unit) by Application (2026-2031)
 Table 70. Lonza Company Information
 Table 71. Lonza Description and Business Overview
 Table 72. Lonza Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Lonza Induced Pluripotent Stem Cells Production Product
 Table 74. Lonza Recent Developments/Updates
 Table 75. Axol Bioscience Ltd. Company Information
 Table 76. Axol Bioscience Ltd. Description and Business Overview
 Table 77. Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Product
 Table 79. Axol Bioscience Ltd. Recent Developments/Updates
 Table 80. Evotec Company Information
 Table 81. Evotec Description and Business Overview
 Table 82. Evotec Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Evotec Induced Pluripotent Stem Cells Production Product
 Table 84. Evotec Recent Developments/Updates
 Table 85. Hitachi Ltd. Company Information
 Table 86. Hitachi Ltd. Description and Business Overview
 Table 87. Hitachi Ltd. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Hitachi Ltd. Induced Pluripotent Stem Cells Production Product
 Table 89. Hitachi Ltd. Recent Developments/Updates
 Table 90. Merck KGaA Company Information
 Table 91. Merck KGaA Description and Business Overview
 Table 92. Merck KGaA Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Merck KGaA Induced Pluripotent Stem Cells Production Product
 Table 94. Merck KGaA Recent Developments/Updates
 Table 95. REPROCELL Inc. Company Information
 Table 96. REPROCELL Inc. Description and Business Overview
 Table 97. REPROCELL Inc. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. REPROCELL Inc. Induced Pluripotent Stem Cells Production Product
 Table 99. REPROCELL Inc. Recent Developments/Updates
 Table 100. Fate Therapeutics Company Information
 Table 101. Fate Therapeutics Description and Business Overview
 Table 102. Fate Therapeutics Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Fate Therapeutics Induced Pluripotent Stem Cells Production Product
 Table 104. Fate Therapeutics Recent Developments/Updates
 Table 105. Thermo Fisher Scientific, Inc. Company Information
 Table 106. Thermo Fisher Scientific, Inc. Description and Business Overview
 Table 107. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Product
 Table 109. Thermo Fisher Scientific, Inc. Recent Developments/Updates
 Table 110. StemCellFactory III Company Information
 Table 111. StemCellFactory III Description and Business Overview
 Table 112. StemCellFactory III Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. StemCellFactory III Induced Pluripotent Stem Cells Production Product
 Table 114. StemCellFactory III Recent Developments/Updates
 Table 115. Applied StemCell Inc. Company Information
 Table 116. Applied StemCell Inc. Description and Business Overview
 Table 117. Applied StemCell Inc. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Applied StemCell Inc. Induced Pluripotent Stem Cells Production Product
 Table 119. Applied StemCell Inc. Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Induced Pluripotent Stem Cells Production Distributors List
 Table 123. Induced Pluripotent Stem Cells Production Customers List
 Table 124. Induced Pluripotent Stem Cells Production Market Trends
 Table 125. Induced Pluripotent Stem Cells Production Market Drivers
 Table 126. Induced Pluripotent Stem Cells Production Market Challenges
 Table 127. Induced Pluripotent Stem Cells Production Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Induced Pluripotent Stem Cells Production
 Figure 2. Global Induced Pluripotent Stem Cells Production Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Induced Pluripotent Stem Cells Production Market Share by Type: 2024 & 2031
 Figure 4. Hepatocytes Product Picture
 Figure 5. Fibroblasts Product Picture
 Figure 6. Keratinocytes Product Picture
 Figure 7. Amniotic Cells Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Induced Pluripotent Stem Cells Production Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Induced Pluripotent Stem Cells Production Market Share by Application: 2024 & 2031
 Figure 11. Academic Research
 Figure 12. Drug Development
 Figure 13. Toxicity Screening
 Figure 14. Regenerative Medicine
 Figure 15. Global Induced Pluripotent Stem Cells Production Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Induced Pluripotent Stem Cells Production Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Induced Pluripotent Stem Cells Production Sales (2020-2031) & (K Units)
 Figure 18. Global Induced Pluripotent Stem Cells Production Average Price (USD/Unit) & (2020-2031)
 Figure 19. Induced Pluripotent Stem Cells Production Report Years Considered
 Figure 20. Induced Pluripotent Stem Cells Production Sales Share by Manufacturers in 2024
 Figure 21. Global Induced Pluripotent Stem Cells Production Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Induced Pluripotent Stem Cells Production Players: Market Share by Revenue in Induced Pluripotent Stem Cells Production in 2024
 Figure 23. Induced Pluripotent Stem Cells Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Induced Pluripotent Stem Cells Production Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Induced Pluripotent Stem Cells Production Sales Market Share by Country (2020-2031)
 Figure 26. North America Induced Pluripotent Stem Cells Production Revenue Market Share by Country (2020-2031)
 Figure 27. United States Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Induced Pluripotent Stem Cells Production Sales Market Share by Country (2020-2031)
 Figure 30. Europe Induced Pluripotent Stem Cells Production Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Induced Pluripotent Stem Cells Production Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Induced Pluripotent Stem Cells Production Revenue Market Share by Region (2020-2031)
 Figure 38. China Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Induced Pluripotent Stem Cells Production Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Induced Pluripotent Stem Cells Production Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Induced Pluripotent Stem Cells Production Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Induced Pluripotent Stem Cells Production Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Induced Pluripotent Stem Cells Production by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Induced Pluripotent Stem Cells Production by Type (2020-2031)
 Figure 59. Global Induced Pluripotent Stem Cells Production Price (USD/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Induced Pluripotent Stem Cells Production by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Induced Pluripotent Stem Cells Production by Application (2020-2031)
 Figure 62. Global Induced Pluripotent Stem Cells Production Price (USD/Unit) by Application (2020-2031)
 Figure 63. Induced Pluripotent Stem Cells Production Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Induced Pluripotent Stem Cell iPSC Reprogramming Kit Market Research Report 2025
Global Pluripotent Stem Cell Culture Medium Market Research Report 2024
Global Induced Pluripotent Stem Cells iPSCs Market Insights Forecast to 2030
Global Cell Reprogramming Market Research Report 2025
Global Stem Cell Lines Manufacturing Market Research Report 2024
Global Epithelial Stem Cells Market Research Report 2025
Global Cell Based Regenerative Therapy Market Research Report 2024
Global Pluripotin SC1 Market Research Report 2025
Global Plant Stem Cell Market Research Report 2025
Global Tissue Engineering and Regeneration Market Research Report 2025
Global Human Induced Pluripotent Stem Cells iPSCs Market Research Report 2024
Global Stem Cell Source Market Research Report 2024
Global Cell Therapy Manufacturing Market Research Report 2025
Global Induced Pluripotent Stem Cells Service Market Research Report 2024
Plant Based Stem Cell Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Stem Cell Equipment Market Research Report 2024
Global Stem Cell Growth Factors Market Research Report 2025
Global Induced Pluripotent Stem Cells iPSCs Culture Medium Market Research Report 2024
Global Adult Stem Cell Storage Market Research Report 2025
Global Human Embryonic Stem Cell Assay Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions